# Effect of Sacubitril-Valsartan on Cardiac Structure and Function

> **NCT06693674** · PHASE3 · RECRUITING · sponsor: **Mayo Clinic** · enrollment: 45 (estimated)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** Entresto Pill
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06693674
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-03
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2025-10-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06693674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06693674, "Effect of Sacubitril-Valsartan on Cardiac Structure and Function". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06693674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*